CHATTANOOGA, TENN. – Erlanger is pleased to announce the appointment of Dr. Jensen Hyde as Chief Medical Officer (CMO) for the health system. With an extensive background in medicine, exemplary leadership skills, and a proven track record of enhancing healthcare practices, Dr. Hyde is poised to lead the organization into a new era of transformative healthcare. She is the first female CMO to lead the 130-year-old health system.
As CMO, Dr. Hyde will play a pivotal role in shaping the strategic direction of Erlanger and ensuring that the highest standards of medical care are maintained across the health system. With a deep understanding of the ever-evolving healthcare landscape, she will collaborate with our talented team of physicians, nurses, and healthcare professionals to drive innovation, foster a culture of continuous learning, and further elevate patient outcomes.
Jim Coleman, Erlanger President and CEO, stated, “Dr. Jensen Hyde has been an invaluable member of our team, and we are confident that her exceptional skills, experience, and dedication will be instrumental in leading our healthcare system to new heights. Throughout her tenure with Erlanger, Dr. Hyde has demonstrated a deep commitment to patient care, and we are thrilled to have her take on this pivotal leadership position.”
Previously, Dr. Hyde served as Chief Medical Quality Officer for Erlanger Medical Group and as a hospitalist at Erlanger. Dr. Hyde also holds assistant professor appointments with UTHSC for the Department of Internal Medicine, including Associate Program Director. She has served on multiple committees, including Pharmacy and Therapeutics, Medication Safety, and Internal Medicine Program Evaluation, to name a few.
Dr. Hyde, a board-certified internal medicine physician, earned her medical degree from the University of Tennessee Health Science Center in 2014. She completed her internship and residency in Internal Medicine at UTHSC Chattanooga before earning a Master of Public Health from Columbia University in 2020. She has earned several awards, including “Distinguished Women in Medicine and Top Doctor in Internal Medicine” by Top Doctors and Resident of the Year at UTHSC Chattanooga for 2016. Dr. Hyde has also been published in multiple peer-reviewed journals. Throughout her career, Dr. Hyde has excelled as a medical practitioner, contributing significantly to advancements in medical science and patient care.
“I am excited for this new chapter with the exceptional team at Erlanger,” said Dr. Hyde. “Together, we will build upon the strong foundation already in place and strive to achieve new heights in delivering compassionate, personalized, and evidence-based healthcare to our community.”
Dr. Hyde’s appointment as CMO comes at a pivotal moment for Erlanger, as it continues to expand services, integrate cutting-edge technologies, and prioritize patient well-being in all our endeavors.
Erlanger News 
[…] Tenn.-based Erlanger Health has appointed Jensen Hyde, MD, as chief medical officer, making her the first female CMO in the system’s […]